Epidermolysis Bullosa Simplex Autosomal Recessive - Clinical Trials

Title: Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita

Recruitment: Recent status unknown (Dec. 2013)
Conditions: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A))/Drug: Placebo
URL: http://ClinicalTrials.gov/show/NCT00936533

Title: Diacerein for the Treatment of Epidermolysis Bullosa Simplex

Recruitment: Planned. Date of first enrollment: 2014/05/01
Conditions: Epidermolysis bullosa simplex
Interventions: 1 Arm: once daily applied 1% diacerein cream. 2 Arm: Placebo.
URL: https://drks-neu.uniklinik-freiburg.de/drks_web/setLocale_EN.do

Title: Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa

Recruitment: Not yet open for recruitment (Dec 2013)
Conditions: EB simplex, dystrophic EB, junctional EB
Interventions: Drug: 3% SD-101 dermal cream;
Drug: 6% SD-101 dermal cream;
Drug: Vehicle (0% SD-101)
URL: http://www.clinicaltrials.gov/ct2/show/NCT02014376